Novel Device Promising in AD Despite Missed Primary Endpoint

Author profile image Aggregator
0 comments
A noninvasive audiovisual stimulation device for Alzheimerโ€™s disease misses the primary endpoint in the phase 3 HOPE trial but shows an encouraging signal of benefit in mild disease.
Medscape Medical News

Source: Medscape Neurology Published 19 Nov 2026 Imported 19 Nov 2026 Relevancy: Not reviewed

Read the article